Correction: The db/db mouse: a useful model for the study of diabetic retinal neurodegeneration (PLoS ONE (2014) 9, 5 (e97302) DOI: 10.1371/journal.pone.0097302);The db/db mouse: A useful model for the study of diabetic retinal neurodegeneration

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Bogdanov, Patricia ^a,b   Corraliza, Lidia ^a,b   Villena, Josep A ^a,b   Carvalho, Andrea R ^a,b   Garcia Arumí, José ^a,b   Ramos, David ^a   Ruberte, Jesús ^a   Simó, Rafael ^a,b   Hernández, Cristina ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EXCITATORY AMINO ACID TRANSPORTER; GLUCOSE; GLUTAMIC ACID; TRANSCRIPTOME; UNCOUPLING PROTEIN 2; GLUTAMATE TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DB DB MOUSE; DIABETIC RETINOPATHY; DIET THERAPY; DISEASE COURSE; ELECTRORETINOGRAPHY; GENE EXPRESSION; GLIA; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; MOUSE STRAIN; NERVE CELL; NEUROTRANSMISSION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RETINA DEGENERATION; AGE; ANIMAL; C57BL MOUSE; COMPLICATION; DISEASE MODEL; DNA MICROARRAY; GENE EXPRESSION PROFILING; METABOLISM; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; RETINAL DEGENERATION; TRANSMISSION ELECTRON MICROSCOPY;

AGE FACTORS; AMINO ACID TRANSPORT SYSTEM X-AG; ANIMALS; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DISEASE MODELS, ANIMAL; ELECTRORETINOGRAPHY; GENE EXPRESSION PROFILING; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, TRANSMISSION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; RETINAL DEGENERATION; STATISTICS, NONPARAMETRIC;

EID: 84901319791     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106227     Document Type: Erratum

References (65)

1. Cheung N, Mitchell P, Wong TY (2010) Diabetic retinopathy. Lancet 376: 124-136.
2. Simó R, Hernández C (2009) Advances in the medical treatment of diabetic retinopathy. Diabetes Care 32: 1556-1562.
3. Simó R, Hernández C (2008) Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy. Diabetologia 51: 1574-1580.
4. Antonetti DA, Barber AJ, Bronson SK, Freeman WM, Gardner TW, et al. (2006) JDRF Diabetic Retinopathy Center Group. Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes 55: 2401-2411. (Pubitemid 44871140)
5. Fletcher EL, Phipps JA, Ward MM, Puthussery T, Wilkinson-Berka JL (2007) Neuronal and glial cell abnormality as predictors of progression of diabetic retinopathy. Curr Pharm Des 13: 2699-2712. (Pubitemid 47423662)
6. Carrasco E, Hernandez C, Miralles A, Huguet P, Farres J, et al. (2007) Lower somatostatin expression is an early event in diabetic retinopathy and is associated with retinal neurodegeneration. Diabetes Care 30: 2902-2908. (Pubitemid 350083143)
7. Barber AJ, Gardner TW, Abcouwer SF (2011) The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy. Invest Ophthalmol Vis Sci 52: 1156-1163.
8. Antonetti DA, Klein R, Gardner TW (2012) Diabetic Retinopathy. New Engl J Med 366: 1227-1239.
9. Kusari J, Zhou S, Padillo E, Clarke KG, Gil DW (2007) Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats. Invest Ophthalmol Vis Sci 48: 5152-5159. (Pubitemid 351260926)
10. Feng Y, Wang Y, Stock O, Pfister F, Tanimoto N, et al. (2009) Vasoregression linked to neuronal damage in the rat with defect of polycystin-2. PLoS One 4: e7328.
11. Kusari J, Zhou S, Padillo E, Clarke KG, Gil DW (2010) Inhibition of vitreoretinal VEGF elevation and blood-retinal barrier breakdown in streptozotocin-induced diabetic rats by brimonidine. Invest Ophthalmol Vis Sci 51: 1044-1051.
12. Cervantes-Villagrana AR, Garcia-Román, González-Espinosa C, Lamas M (2010) Pharmacological inhibition of N-methyl d-aspartate receptor promotes secretion of vascular endothelial growth factor in Müller cells: effects of hyperglycemia and hypoxia. Curr Eye Res 35: 733-741.
13. Feng Y, Wang Y, Li L, Wu L, Hoffmann S, et al. (2011) Gene expression profiling of vasoregression in the retina-involvement of microglial cells. PLoS One 6: e16865.
14. Imai H, Singh RS, Fort PE, Gardner TW (2009) Neuroprotection for diabetic retinopathy. Dev Ophthalmol 44: 56-68.
15. Simó R, Hernández C, European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR) (2012) Neurodegeneration is an early event in diabetic retinopathy: therapeutic implications. Br J Ophthalmol 96: 1285-1290.
16. Phipps JA, Fletcher EL, Vingrys AJ (2004) Paired-flash identification of rod and cone dysfunction in the diabetic rat. Invest Ophthalmol Vis Sci 45: 4592-4600. (Pubitemid 39564688)
17. Robinson R, Barathi VA, Chaurasia SS, Wong TY, Kern TS (2012) Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals. Dis Model Mech 5: 444-456.
18. Clements RS Jr, Robison WG Jr, Cohen MP (1998) Anti-glycated albumin therapy ameliorates early retinal microvascular pathology in db/db mice. J Diabetes Complications 12: 28-33.
19. Cheung AK, Fung MK, Lo AC, Lam TT, So KF, et al. (2005) Aldose reductase deficiency prevents diabetes-induced blood-retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db mice. Diabetes 54: 3119-3125. (Pubitemid 43334364)
20. Li J, Wang JJ, Chen D, Mott R, Yu Q, et al. (2009) Systemic administration of HMG-CoA reductase inhibitor protects the blood-retinal barrier and ameliorates retinal inflammation in type 2 diabetes. Exp Eye Res 89: 71-78.
21. Li J, Wang JJ, Yu Q, Chen K, Mahadev K, et al.(2010) Inhibition of reactive oxygen species by Lovastatin downregulates vascular endothelial growth factor expression and ameliorates blood-retinal barrier breakdown in db/db mice: role of NADPH oxidase 4. Diabetes 59: 1528-1538.
22. Tang L, Zhang Y, Jiang Y, Willard L, Ortiz E, et al (2011) Dietary wolfberry ameliorates retinal structure abnormalities in db/db mice at the early stage of diabetes. Exp Biol Med (Maywood) 236: 1051-1063.
23. Xiao C, He M, Nan Y, Zhang D, Chen B, et al. (2012) Physiological effects of superoxide dismutase on altered visual function of retinal ganglion cells in db/db mice. PLoS One 7: e30343.
24. Marmor MF, Holder GE, Seeliger MW, Yamamoto S, International Society for Clinical Electrophysiology of Vision (2004). Standard for clinical electroretinography. Doc Ophthalmol 108: 107-114.
25. Anderson PJ, Watts H, Hille C, Philpott K, Clark P, et al. (2008) Glial and endothelial blood-retinal barrier responses to amyloid-beta in the neural retina of the rat. Clin Ophthalmol 2: 801-816.
26. T. Methods, 25: 408-411.
27. Bayer AU, Neuhardt T, May AC, Martus P, Maag KP, et al. (2001) Retinal morphology and ERG response in the DBA/2NNia mouse model of angle-closure glaucoma. Invest Ophthalmol Vis Sci 42: 1258-1265. (Pubitemid 32381967)
28. Schmucker C, Schaeffel F (2004) A paraxial schematic eye model for the growing C57BL/6 mouse. Vision Res 44: 1857-1867. (Pubitemid 38624338)
29. Garcia-Ramírez M, Hernández C, Villarroel M, Canals F, Alonso MA, et al. (2009) Interphotoreceptor retinoid-binding protein (IRBP) is downregulated at early stages of diabetic retinopathy. Diabetologia 52: 2633-2641.
30. Harrison WW, Bearse MA, Ng J, Jewell NP, Barez S, et al. (2011) Multifocal electroretinograms predict onset of diabetic retinopathy in adult patients with diabetes. Invest Ophthalmol Vis Sci 52: 772-777.
31. Ng JS, Bearse MA Jr, Schneck ME, Barez S, Adams AJ (2008) Local diabetic retinopathy prediction by multifocal ERG delays over 3 years. Invest Ophthalmol Vis Sci 49: 1622-1628.
32. Lecleire-Collet A, Audo I, Aout M, Girmens JF, Sofroni R, et al. (2011) Evaluation of retinal function flicker light-induced retinal vascular response in normotensive patients with diabetes without retinopathy. Invest Ophthalmol Vis Sci 52: 2861-2867.
33. Tyberg M, Lindblad U, Melander A, Lövestam-Adrian M, Ponjavic V, et al. (2011) Electrophysiological studies in newly onset type 2 diabetes without visible vascular retinopathy. Doc Ophthalmol 123: 193-198.
34. Riva CE, Logean E, Falsini B (2005) Visually evoked hemodynamical response and assessment of neurovascular coupling in the optic nerve and retina. Prog Retin Eye Res 24: 183-215. (Pubitemid 40018224)
35. Bearse MA Jr, Adams AJ, Han Y, Schneck ME, Ng J, et al. (2006) A multifocal electroretinogram model predicting the development of diabetic retinopathy. Prog Retin Eye Res 25: 425-448. (Pubitemid 44380399)
36. Bronson-Castain KW, Bearse MA Jr, Neuville J, Jonasdottir S, King-Hooper B, et al. (2009) Adolescents with Type 2 diabetes: early indications of focal retinal neuropathy, retinal thinning, and venular dilation. Retina 29: 618-626.
37. Han Y, Schneck ME, Bearse MA Jr, Barez S, Jacobsen CH, et al. (2004) Formulation and evaluation of a predictive model to identify the sites of future diabetic retinopathy. Invest Ophthalmol Vis Sci 45: 4106-4112. (Pubitemid 39411167)
38. Kern TS, Barber AJ (2008) Retinal ganglion cells in diabetes. J Physiol 586: 4401-4408.
39. Lopes de Faria JM, Russ H, Costa VP (2002) Retinal nerve fibre layer loss in patients with type 1 diabetes mellitus without retinopathy. Br J Ophthalmol 86: 725-728. (Pubitemid 34713154)
40. van Dijk HW, Verbraak FD, Stehouwer M, Kok PH, Garvin MK, et al. (2011) Association of visual function and ganglion cell layer thickness in patients with diabetes mellitus type 1 and no or minimal diabetic retinopathy. Vision Res 28: 224-228.
41. van Dijk HW, Verbraak FD, Kok PH, Stehouwer M, Garvin MK, et al. (2012) Early neurodegeneration in the retina of type 2 diabetic patients. Invest Ophthalmol Vis Sci 53: 2715-2719.
42. Mizutani M, Gerhardinger C, Lorenzi M (1998) Müller cell changes in human diabetic retinopathy. Diabetes 47: 445-449. (Pubitemid 28104208)
43. Akita mouse as a model of early complications in diabetes. Invest Ophthalmol Vis Sci 46: 2210-2218.
44. Valverde AM, Miranda S, García-Ramírez M, González-Rodriguez A, Hernández C, et al. (2013) Pro-apoptotic and survival signaling in the neuroretina at early stages of diabetic retinopathy. Mol Vis 19: 47-53.
45. Holopigian K, Seiple W, Lorenzo M, Carr R (1992) A comparison of photopic and scotopic electroretinographic changes in early diabetic retinopathy. Invest Ophthalmol Vis Sci 33: 2773-2780.
46. Shirao Y, Kawasaki K (1998) Electrical responses from diabetic retina. Prog Retin Eye Res 17: 59-76. (Pubitemid 28040753)
47. Wachtmeister L (1987) Basic research and clinical aspects of the oscillatory potentials of the electroretinogram. Doc Ophthalmol 66: 187-194.
48. Kline RP, Ripps H, Dowling JE (1978) Generation of b-wave currents in the skate retina. Proc Natl Acad Sci USA 75: 5727-5731. (Pubitemid 9101468)
49. Klemp K, Sander B, Brockhoff PB, Vaag A, Lund-Andersen H, et al. (2005) The multifocal ERG in diabetic patients without retinopathy during euglycemic clamping. Invest Ophthalmol Vis Sci 46: 2620-2626. (Pubitemid 43119514)
50. Lieth E, Barber AJ, Xu B, Dice C, Ratz MJ, et al. (1988) Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group. Diabetes 47: 815-820.
51. Lieth E, LaNoue KF, Antonetti DA, Ratz M (2000) Diabetes reduces glutamate oxidation and glutamine synthesis in the retina. The Penn State Retina Research Group. Exp Eye 70: 723-730.
52. Kowluru RA, Engerman RL, Case GL, Kern TS (2001) Retinal glutamate in diabetes and effect of antioxidants. Neurochem Int 38: 385-390. (Pubitemid 32166895)
53. Ambati J, Chalam KV, Chawla DK, D'Angio CT, Guillet EG, et al. (1997) Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol 115: 1161-1166. (Pubitemid 27387953)
54. Barnstable CJ (1993) Glutamate and GABA in retinal circuitry. Curr Opin Neurobiol 3: 520-525.
55. Sarthy VP, Pignataro L, Pannicke T, Weick M, Reichenbach A, et al. (2005) Glutamate transport by retinal Muller cells in glutamate/aspartate transporter-knockout mice. Glia 49: 184-196. (Pubitemid 40188498)
56. Hernández C, García-Ramírez M, Corraliza L, Fernández-Carneado J, Farrera-Sinfreu J, et al. (2013). Topical administration of somatostatin prevents retinal neurodegeneration in experimental diabetes. Diabetes 62: 2569-78.
57. Zhang Y, Zhang J, Wang Q, Lei X, Chu Q, et al. (2011) Intravitreal injection of exendin-4 analogue protects retinal cells in early diabetic rats. Invest Ophthalmol Vis Sci 52: 278-285.
58. Ng YK, Zeng XX, Ling EA (2004) Expression of glutamate receptors and calcium-binding proteins in the retina of streptozotocin-induced diabetic rats. Brain Res 1018: 66-72.
59. Santiago AR, Gaspar JM, Baptista FI, Cristóvão AJ, Santos PF, et al. (2009) Diabetes changes the levels of ionotropic glutamate receptors in the rat retina. Mol Vis 15: 1620-1630.
60. Lau JC, Kroes RA, Moskal JR, Linsenmeier RA (2013) Diabetes changes expression of genes related to glutamate neurotransmission and transport in the Long-Evans rat retina. Mol Vis 19: 1538-1553.
61. Silva KC, Rosales MA, Hamassaki DE, Saito KC, Faria AM, et al. (2013) Green tea is neuroprotective in diabetic retinopathy. Invest Ophthalmol Vis Sci 54: 1325-1336.
62. Ju WK, Kim KY, Angert M, Duong-Polk KX, Lindsey JD, et al. (2009) Memantine blocks mitochondrial OPA1 and cytochrome c release and subsequent apoptotic cell death in glaucomatous retina. Invest Ophthalmol Vis Sci 50: 707-716.
63. Ju WK, Lindsey JD, Angert M, Patel A, Weinreb RN (2008) Glutamate receptor activation triggers OPA1 release and induces apoptotic cell death in ischemic rat retina. Mol Vis 14: 2629-2638.
64. Markowitz AJ, White MG, Kolson DL, Jordan-Sciutto KL (2007) Cellular interplay between neurons and glia: toward a comprehensive mechanism for excitotoxic neuronal loss in neurodegeneration. Cellscience 4: 111-146.
65. Nguyen D, Alavi MV, Kim KY, Kang T, Scott RT, et al. (2011) A new vicious cycle involving glutamate excitotoxicity, oxidative stress and mitochondrial dynamics. Cell Death Dis 8;2: e240.